Medical Devices Startups
6,515 companies tagged Medical Devices, with their investors and founders.
Amend Surgical develops suture-less nerve repair devices using resorbable hydrogel technology licensed from Harvard's Wyss Institute. The company serves surgeons and hospitals treating peripheral nerve injuries.
0 investors
American Pain Consortium operates a national platform supporting interventional pain management clinics and physicians, providing clinical services such as spinal cord stimulators, infusion therapy, diagnostic imaging, and physical therapy for patients with chronic and neuropathic pain. It also offers practice management services including licensure, compliance monitoring, revenue cycle management, medical billing, and physician recruitment.
0 investors
Amplifi Vascular develops the Amplifi Vein Dilation System, a wearable external blood pump with inflow and outflow catheters that uses proprietary hemodynamic technology to enlarge veins before arteriovenous fistula (AVF) creation. The device is intended to increase patient eligibility for AVF surgery and improve vascular access outcomes for hemodialysis patients.
0 investors
AmSurg operates a network of ambulatory surgery centers and endoscopy facilities across the United States offering surgical services across multiple specialties including gastroenterology, ophthalmology, orthopedics, and general surgery.
0 investors
Amydis develops proprietary ocular tracers that detect molecular biomarkers for diseases of the eye, heart, and brain through non-invasive eye-based testing. It builds a multi-omics data warehouse and AI-enabled health insights to support earlier diagnosis and precision treatment.
0 investors
Ananda Scientific develops investigational CBD-based drugs delivered in soft gelatin capsules, with its Nantheia A1002N5S product formulated for rapid gastrointestinal absorption. The company is running FDA-approved clinical trials targeting PTSD, Social Anxiety Disorder, and radiculopathic pain, focusing on treatments for neuropsychiatric disorders.
0 investors
Anaxiom develops a minimally invasive implantable device to treat obesity by modulating blood flow, offering an alternative to surgery and medication for patients and physicians seeking weight loss solutions.
0 investors
Ancora Heart develops minimally invasive medical devices, including a class III implantable therapy for cardiovascular treatment. The company focuses on cardiac/heart failure therapy development, clinical research, and commercialization of its core technology.
0 investors
Animerra develops next-generation biologics for companion animal health, applying therapeutic innovation from human medicine to veterinary treatment. The company targets pet owners and veterinary markets with innovative protein-based therapeutics and biologics treatments.
0 investors
Ankasa is developing ART352-L, a regenerative medicine designed to enhance bone formation in reconstructive surgeries, with initial focus on spinal fusion procedures to treat degenerative disc disease. The therapy aims to improve healing outcomes and reduce revision surgeries for patients requiring bone reconstruction.
0 investors
Antidote Therapeutics is a biotechnology company focused on drug discovery and development, led by an experienced team with backgrounds in clinical trials, pharmaceutical development, and biomarker-driven innovation.
0 investors
APEX Orthopedics Investments (AOI) is an asset management group led by foot and ankle surgeons that develops, invests in, and manages portfolio companies building Class II and Class III orthopedic devices. Its initial focus is the foot and ankle market, with support across clinical, product development, regulatory, operational, and marketing functions.
0 investors
Apex provides ALS and BLS ambulance services across the Denver and Colorado Springs metro areas, offering emergency medical transport with real-time ambulance tracking for patients and facilities. It serves hospitals and healthcare facilities in the region through its EMS Loop tracking technology.
0 investors
ApiJect develops a platform for producing prefilled injectable medicines and vaccines, aimed at making injectable drug delivery safer and more accessible. It serves manufacturers of sterile liquid products in the pharmaceutical and healthcare industry.
0 investors
ApolloMed Innovations supplies aesthetic products and devices to physicians and aesthetic practitioners, along with clinical training and hands-on support for advanced procedures. The company aims to help practices meet patient needs while adding new revenue streams.
0 investors
Aponia Laboratories is a specialized pharmaceutical company developing topical prescription and over-the-counter pain relief products based on ibuprofen for the NSAID segment of the arthritis pain market. Its products have completed formulation development and non-clinical studies and are undergoing FDA-guided clinical trials.
0 investors
Applied Biological Laboratories develops antiviral biotechnology treatments targeting respiratory viruses using a patented biologic platform that combines host-directed immune modulation and microbe-directed mechanisms. The company conducts research using human respiratory organoids to identify and develop antiviral and anti-inflammatory therapeutic solutions.
0 investors
Arc Techtonics develops orthopedic trauma medical devices, with a flagship CounterArc Plating System built on patented anatomic multiplanar technology for complex fracture repair. The plates use continuous arc struts, orthogonal screw fixation, and a wedge window design intended to improve fixation strength and bone grafting for orthopedic surgeons.
0 investors
Arch Therapeutics develops the AC5 Advanced Wound System, a wound care product available in the USA for both government and non-government purchasers. The company operates in the medical device sector focused on wound management.
0 investors
ArcScan develops ophthalmic diagnostic imaging technology, including very high-frequency digital ultrasound systems for measuring the cornea and anterior segment of the eye. Its products support refractive surgery applications such as keratoconus screening and corneal epithelium measurement.
0 investors
Armis Biopharma develops targeted antimicrobial therapies designed to treat and prevent localized, drug-resistant infections by delivering medications locally to increase efficacy and reduce systemic toxicity.
0 investors
Arsenal Medical develops a platform of biomaterials for medical applications, including ResQFoam for hemorrhage control and NeoCast, advancing products through clinical trials and FDA regulatory pathways. The company focuses on biomaterial-based medical devices and combination products across clinical indications.
0 investors
Artelo Biosciences develops therapeutic treatments by modifying lipid signaling pathways to treat cancer and other serious conditions at the clinical stage.
0 investors
Artelon develops synthetic ligament and tendon reconstruction products based on its Dynamic Matrix technology for orthopedic soft tissue repair. Its implants, used in joint stability and kinematics procedures, have been implanted over 60,000 times worldwide, and the company is now part of Stryker.
0 investors